<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using two-dimensional echocardiography, we studied the pathophysiology of <z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">intracardiac thrombus</z:e> regression accompanied by <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy in 82 consecutive patients with <z:hpo ids='HP_0011009'>acute</z:hpo> cardiogenic <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We noted <z:e sem="disease" ids="C0876998" disease_type="Disease or Syndrome" abbrv="">intracardiac thrombus</z:e> in 15 patients; nine of the 15 were started on <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy with <z:chebi fb="0" ids="32301">warfarin potassium</z:chebi> to maintain the prothrombin time between 2.5 and 3.5 (international normalized ratio) </plain></SENT>
<SENT sid="2" pm="."><plain>Serial two-dimensional echocardiograms were obtained for these nine patients before and after anticoagulation, with the plasma levels of fibrinopeptide A, fibrinopeptide B beta 15-42, and D-dimer measured at the same time </plain></SENT>
<SENT sid="3" pm="."><plain>In eight of the nine patients the intracardiac <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> gradually decreased in size while the plasma level of fibrinopeptide A fell to within the <z:mpath ids='MPATH_458'>normal</z:mpath> range and the plasma levels of fibrinopeptide B beta 15-42 and D-dimer remained above the <z:mpath ids='MPATH_458'>normal</z:mpath> ranges </plain></SENT>
<SENT sid="4" pm="."><plain>In the other patient the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> disappeared, with embolization to the right arm immediately after starting <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Mobile or small <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> regressed earlier than nonmobile or large ones </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that regression of intracardiac <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> after anticoagulation may be based on the relative predominance of plasma fibrinolytic activity over anticoagulation-inhibited thrombin activity </plain></SENT>
</text></document>